Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Orthopedic Oncology received 61 citations as per Google Scholar report
Immunotherapy for osteosarcoma utilizes the body's immune system to target and destroy cancer cells. This approach includes various strategies such as checkpoint inhibitors, CAR-T cell therapy, and monoclonal antibodies.
Immunotherapy for osteosarcoma aims to enhance the immune system's ability to recognize and attack cancer cells. Techniques like checkpoint inhibitors block proteins that inhibit immune response, while CAR-T cell therapy involves engineering a patient’s T-cells to target cancer-specific antigens. Monoclonal antibodies can also be used to mark cancer cells for destruction. This innovative approach seeks to provide new treatment options for osteosarcoma, especially in cases resistant to conventional therapies, offering the potential for more effective and targeted treatment strategies.